L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3084
ETF rank
ยฃ14.53 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ10.20
Share price
-0.03%
Change (1 day)
28.33%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of December 2025: 0.49%